181 related articles for article (PubMed ID: 31524156)
41. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
42. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease.
Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
Psychogeriatrics; 2016 Jan; 16(1):3-11. PubMed ID: 25919635
[TBL] [Abstract][Full Text] [Related]
44. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
45. The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
Babić Leko M; Jurasović J; Nikolac Perković M; Španić E; Sekovanić A; Orct T; Lukinović Škudar V; Bačić Baronica K; Kiđemet-Piskač S; Vogrinc Ž; Pivac N; Borovečki F; Hof PR; Šimić G
J Alzheimers Dis; 2021; 82(2):661-672. PubMed ID: 34057084
[TBL] [Abstract][Full Text] [Related]
46. Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma.
Baker-Nigh AT; Mawuenyega KG; Bollinger JG; Ovod V; Kasten T; Franklin EE; Liao F; Jiang H; Holtzman D; Cairns NJ; Morris JC; Bateman RJ
J Biol Chem; 2016 Dec; 291(53):27204-27218. PubMed ID: 27793990
[TBL] [Abstract][Full Text] [Related]
47. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
[TBL] [Abstract][Full Text] [Related]
48. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
49. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
50. Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
Johnson CN; McCoin CS; Kueck PJ; Hawley AG; John CS; Thyfault JP; Swerdlow RH; Geiger PC; Morris JK
J Alzheimers Dis; 2023; 92(3):1027-1035. PubMed ID: 36847010
[TBL] [Abstract][Full Text] [Related]
51. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.
Golombowski S; Müller-Spahn F; Romig H; Mendla K; Hock C
Neurosci Lett; 1997 Apr; 225(3):213-5. PubMed ID: 9147408
[TBL] [Abstract][Full Text] [Related]
52. APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.
Abdullah L; Evans JE; Emmerich T; Crynen G; Shackleton B; Keegan AP; Luis C; Tai L; LaDu MJ; Mullan M; Crawford F; Bachmeier C
Aging (Albany NY); 2017 Mar; 9(3):964-985. PubMed ID: 28333036
[TBL] [Abstract][Full Text] [Related]
53. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
54. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
[TBL] [Abstract][Full Text] [Related]
55. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
[TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.
Elliott DA; Halliday GM; Garner B
BMC Neurosci; 2010 Feb; 11():23. PubMed ID: 20170526
[TBL] [Abstract][Full Text] [Related]
57. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly.
Slot RER; Kester MI; Van Harten AC; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; van der Flier WM; Veerhuis R
Neurobiol Aging; 2019 Jul; 79():101-109. PubMed ID: 31029938
[TBL] [Abstract][Full Text] [Related]
58. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
[TBL] [Abstract][Full Text] [Related]
59. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
[TBL] [Abstract][Full Text] [Related]
60. The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
Benussi L; Ghidoni R; Dal Piaz F; Binetti G; Di Iorio G; Abrescia P
J Alzheimers Dis; 2017; 56(2):825-833. PubMed ID: 27983556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
